<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Mindwalk Holdings Corp. — News on 6ix</title>
<link>https://6ix.com/company/mindwalk-holdings-corp</link>
<description>Latest news and press releases for Mindwalk Holdings Corp. on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Thu, 12 Mar 2026 04:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/mindwalk-holdings-corp" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo69d75c8d51cc36e4753387f7.webp</url>
<title>Mindwalk Holdings Corp.</title>
<link>https://6ix.com/company/mindwalk-holdings-corp</link>
</image>
<item>
<title>MindWalk Holdings Corp. Reports Q3 Fiscal 2026 Financial Results</title>
<link>https://6ix.com/company/mindwalk-holdings-corp/news/mindwalk-holdings-corp-reports-q3-fiscal-2026-financial-results-12</link>
<guid isPermaLink="true">https://6ix.com/company/mindwalk-holdings-corp/news/mindwalk-holdings-corp-reports-q3-fiscal-2026-financial-results-12</guid>
<pubDate>Thu, 12 Mar 2026 04:00:00 GMT</pubDate>
<description>Third Consecutive Quarter of Year-Over-Year Revenue Growth | First Annual Enterprise LensAI™ Platform Contract | Launch of B cell Llama™ Nanobody Discovery</description>
</item>
<item>
<title>MindWalk Announces B Cell Llama™, a Nanobody Discovery Platform Designed for the Bispecific and Cell Therapy Era</title>
<link>https://6ix.com/company/mindwalk-holdings-corp/news/mindwalk-announces-b-cell-llamatm-a-nanobody-discovery-platform-designed-for-the-bispecific-and-cell-therapy-era-1</link>
<guid isPermaLink="true">https://6ix.com/company/mindwalk-holdings-corp/news/mindwalk-announces-b-cell-llamatm-a-nanobody-discovery-platform-designed-for-the-bispecific-and-cell-therapy-era-1</guid>
<pubDate>Fri, 06 Mar 2026 05:00:00 GMT</pubDate>
<description>Peer-reviewed study in ACS Biomacromolecules demonstrates modular VHH potency, cross-variant therapeutic activity, and a newly described immune-priming</description>
</item>
<item>
<title>MindWalk Holdings Corp. to Report Third Quarter Fiscal Year 2026 Financial Results on March 12, 2026</title>
<link>https://6ix.com/company/mindwalk-holdings-corp/news/mindwalk-holdings-corp-to-report-third-quarter-fiscal-year-2026-financial-results-on-march-12-2026</link>
<guid isPermaLink="true">https://6ix.com/company/mindwalk-holdings-corp/news/mindwalk-holdings-corp-to-report-third-quarter-fiscal-year-2026-financial-results-on-march-12-2026</guid>
<pubDate>Mon, 02 Mar 2026 13:31:00 GMT</pubDate>
<description>AUSTIN, Texas, March 02, 2026--MindWalk Holdings Corp. (NASDAQ:HYFT) ("MindWalk" or the "Company"), a Bio-Native AI therapeutic research and technology company, today announced that it will report financial results for the third quarter of fiscal year 2026 and host a conference call on Thursday, March 12, 2026, at 10:30 AM Eastern Time. Financial results will be issued in a press release prior to the call, which will include a management presentation followed by a question-and-answer session.</description>
</item>
<item>
<title>MindWalk Applies HYFT® Technology to Detect Functional Adjacency Linked to Portfolio Risk in AI-Designed Therapeutics</title>
<link>https://6ix.com/company/mindwalk-holdings-corp/news/mindwalk-applies-hyftr-technology-to-detect-functional-adjacency-linked-to-portfolio-risk-in-ai-designed-therapeutics</link>
<guid isPermaLink="true">https://6ix.com/company/mindwalk-holdings-corp/news/mindwalk-applies-hyftr-technology-to-detect-functional-adjacency-linked-to-portfolio-risk-in-ai-designed-therapeutics</guid>
<pubDate>Tue, 27 Jan 2026 05:01:00 GMT</pubDate>
<description>AUSTIN, Texas, January 27, 2026--MindWalk Holdings Corp. (NASDAQ:HYFT) ("MindWalk" or the "Company"), a Bio-Native AI therapeutic research and technology company, today announced an application of its proprietary HYFT® technology designed to identify functional adjacency - meaning different molecules can produce the same therapeutic effect even when sequence comparisons suggest they are unrelated - an emerging source of competitive, legal, and valuation risk in modern drug discovery that sequenc</description>
</item>
<item>
<title>MindWalk Validates Platform Precision with Breakthrough Discovery Targeting Pathogenic TDP-43 in Neurodegenerative Disease</title>
<link>https://6ix.com/company/mindwalk-holdings-corp/news/mindwalk-validates-platform-precision-with-breakthrough-discovery-targeting-pathogenic-tdp-43-in-neurodegenerative-disease</link>
<guid isPermaLink="true">https://6ix.com/company/mindwalk-holdings-corp/news/mindwalk-validates-platform-precision-with-breakthrough-discovery-targeting-pathogenic-tdp-43-in-neurodegenerative-disease</guid>
<pubDate>Wed, 14 Jan 2026 05:00:00 GMT</pubDate>
<description>VICTORIA, British Columbia--(BUSINESS WIRE)-- MindWalk Holdings Corp. (“MindWalk” or the “Company”) (Nasdaq: HYFT) today announced the discovery and</description>
</item>
<item>
<title>REPEAT/MindWalk Advances Universal Influenza Program with a Breakthrough Functional Insight</title>
<link>https://6ix.com/company/mindwalk-holdings-corp/news/repeatmindwalk-advances-universal-influenza-program-with-a-breakthrough-functional-insight</link>
<guid isPermaLink="true">https://6ix.com/company/mindwalk-holdings-corp/news/repeatmindwalk-advances-universal-influenza-program-with-a-breakthrough-functional-insight</guid>
<pubDate>Mon, 12 Jan 2026 12:00:00 GMT</pubDate>
<description>AUSTIN, Texas, January 12, 2026--MindWalk Holdings Corp. (NASDAQ:HYFT) ("MindWalk" or the "Company"), a Bio-Native AI therapeutic research and technology company, today announced an advance in its universal influenza program following the identification of a breakthrough functional constraint that persists across influenza viruses despite continual evolution.</description>
</item>
<item>
<title>MindWalk Advances Universal Influenza Program with a Breakthrough Functional Insight</title>
<link>https://6ix.com/company/mindwalk-holdings-corp/news/mindwalk-advances-universal-influenza-program-with-a-breakthrough-functional-insight</link>
<guid isPermaLink="true">https://6ix.com/company/mindwalk-holdings-corp/news/mindwalk-advances-universal-influenza-program-with-a-breakthrough-functional-insight</guid>
<pubDate>Fri, 09 Jan 2026 05:00:00 GMT</pubDate>
<description>Validated Across Influenza A and Influenza B, Including H3N2 Subclade K and Zoonotic Influenza A Subtypes H5, H7, H9 AUSTIN, Texas--(BUSINESS WIRE)--</description>
</item>
<item>
<title>MindWalk Reports Record Growth and Announces Strategic Progress on Its AI Asset Pipeline</title>
<link>https://6ix.com/company/mindwalk-holdings-corp/news/mindwalk-reports-record-growth-and-announces-strategic-progress-on-its-ai-asset-pipeline</link>
<guid isPermaLink="true">https://6ix.com/company/mindwalk-holdings-corp/news/mindwalk-reports-record-growth-and-announces-strategic-progress-on-its-ai-asset-pipeline</guid>
<pubDate>Mon, 15 Dec 2025 05:00:00 GMT</pubDate>
<description>VICTORIA, British Columbia--(BUSINESS WIRE)-- MindWalk (NASDAQ: HYFT), a BioNative AI biotherapeutic research and technology company combining in silico and</description>
</item>
<item>
<title>MindWalk Holdings Corp. to Report Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2026 on December 15, 2025</title>
<link>https://6ix.com/company/mindwalk-holdings-corp/news/mindwalk-holdings-corp-to-report-financial-results-and-recent-business-highlights-for-second-quarter-fiscal-year-2026-on-december-15-2025</link>
<guid isPermaLink="true">https://6ix.com/company/mindwalk-holdings-corp/news/mindwalk-holdings-corp-to-report-financial-results-and-recent-business-highlights-for-second-quarter-fiscal-year-2026-on-december-15-2025</guid>
<pubDate>Mon, 08 Dec 2025 13:30:00 GMT</pubDate>
<description>AUSTIN, Texas, December 08, 2025--MindWalk Holdings Corp. (NASDAQ:HYFT) ("MindWalk" or the "Company"), a Bio-Native AI therapeutic research and technology company, today announced that it will host a conference call to discuss its quarterly results and recent business highlights for second quarter fiscal year 2026, on Monday, December 15, 2025, at 10:30 am Eastern Time. The financial results will be issued in a press release prior to the call. MindWalk management will host the conference call fo</description>
</item>
<item>
<title>MindWalk CTO Dr. Dirk Van Hyfte to Join Fireside Chat at AI Drug Discovery & Development Summit 2025</title>
<link>https://6ix.com/company/mindwalk-holdings-corp/news/mindwalk-cto-dr-dirk-van-hyfte-to-join-fireside-chat-at-ai-drug-discovery-and-development-summit-2025</link>
<guid isPermaLink="true">https://6ix.com/company/mindwalk-holdings-corp/news/mindwalk-cto-dr-dirk-van-hyfte-to-join-fireside-chat-at-ai-drug-discovery-and-development-summit-2025</guid>
<pubDate>Thu, 13 Nov 2025 14:00:00 GMT</pubDate>
<description>AUSTIN, Texas, November 13, 2025--MindWalk Holdings Corp.™ ("MindWalk," "Company," "we" or "us") (Nasdaq: HYFT), a Bio-Native AI company, today announced that Dr. Dirk Van Hyfte, Chief Technology Officer, will participate in a fireside chat during the Biology Session at the AI Drug Discovery & Development Summit 2025, taking place on November 20, 2025, from 12:15 PM to 12:45 PM.</description>
</item>
<item>
<title>MindWalk Appoints R. Scott Areglado as Chief Financial Officer to Strengthen Financial Leadership and Support Growth Strategy</title>
<link>https://6ix.com/company/mindwalk-holdings-corp/news/mindwalk-appoints-r-scott-areglado-as-chief-financial-officer-to-strengthen-financial-leadership-and-support-growth-strategy</link>
<guid isPermaLink="true">https://6ix.com/company/mindwalk-holdings-corp/news/mindwalk-appoints-r-scott-areglado-as-chief-financial-officer-to-strengthen-financial-leadership-and-support-growth-strategy</guid>
<pubDate>Tue, 21 Oct 2025 04:00:00 GMT</pubDate>
<description>AUSTIN, Texas--(BUSINESS WIRE)-- MindWalk Holdings Corp.™ (“MindWalk,” “Company,” “we” or “us”) (Nasdaq: HYFT), bio-native AI company today announces the</description>
</item>
<item>
<title>MindWalk Appoints Dr. Thomas W. Lynch as Chief Business Officer to Accelerate Commercial Expansion</title>
<link>https://6ix.com/company/mindwalk-holdings-corp/news/mindwalk-appoints-dr-thomas-w-lynch-as-chief-business-officer-to-accelerate-commercial-expansion</link>
<guid isPermaLink="true">https://6ix.com/company/mindwalk-holdings-corp/news/mindwalk-appoints-dr-thomas-w-lynch-as-chief-business-officer-to-accelerate-commercial-expansion</guid>
<pubDate>Wed, 15 Oct 2025 04:00:00 GMT</pubDate>
<description>AUSTIN, Texas--(BUSINESS WIRE)-- MindWalk Holdings Corp.™ (“MindWalk,” “Company,” “we” or “us”) (Nasdaq: HYFT), a Bio-Native AI company today announced the</description>
</item>
<item>
<title>MindWalk Announces Share Repurchase Program</title>
<link>https://6ix.com/company/mindwalk-holdings-corp/news/mindwalk-announces-share-repurchase-program</link>
<guid isPermaLink="true">https://6ix.com/company/mindwalk-holdings-corp/news/mindwalk-announces-share-repurchase-program</guid>
<pubDate>Thu, 09 Oct 2025 04:00:00 GMT</pubDate>
<description>AUSTIN, Texas--(BUSINESS WIRE)-- MindWalk Holdings Corp. (“MindWalk” or the “Company”) (NASDAQ: “HYFT”), a bio-native AI company, today announced that to</description>
</item>
<item>
<title>MindWalk Advances AI-Designed GLP-1 Program with First-in-Class Dual-Pathway Regimen for Aging and Longevity</title>
<link>https://6ix.com/company/mindwalk-holdings-corp/news/mindwalk-advances-ai-designed-glp-1-program-with-first-in-class-dual-pathway-regimen-for-aging-and-longevity</link>
<guid isPermaLink="true">https://6ix.com/company/mindwalk-holdings-corp/news/mindwalk-advances-ai-designed-glp-1-program-with-first-in-class-dual-pathway-regimen-for-aging-and-longevity</guid>
<pubDate>Mon, 22 Sep 2025 04:00:00 GMT</pubDate>
<description>Company builds on earlier GLP-1 success with breakthrough AI-led insights into aging biology -- targeting the widely projected $60B longevity therapeutics</description>
</item>
<item>
<title>MindWalk Holdings Corp.™ (formerly ImmunoPrecise Antibodies™) Reports Record $7.6 Million Quarterly Revenue, 45% Growth, Margin Expansion, Narrowed Losses, and Strengthened Balance Sheet</title>
<link>https://6ix.com/company/mindwalk-holdings-corp/news/mindwalk-holdings-corptm-formerly-immunoprecise-antibodiestm-reports-record-dollar76-million-quarterly-revenue-45percent-growth-margin-expansion-narrowed-losses-and-strengthened-balance-sheet</link>
<guid isPermaLink="true">https://6ix.com/company/mindwalk-holdings-corp/news/mindwalk-holdings-corptm-formerly-immunoprecise-antibodiestm-reports-record-dollar76-million-quarterly-revenue-45percent-growth-margin-expansion-narrowed-losses-and-strengthened-balance-sheet</guid>
<pubDate>Mon, 15 Sep 2025 04:00:00 GMT</pubDate>
<description>Company to hold conference call on September 15, 2025, at 10:30 ET to review corporate highlights AUSTIN, Texas--(BUSINESS WIRE)-- MindWalk Holdings Corp.™</description>
</item>
<item>
<title>MindWalk to Report Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2026 on September 15, 2025</title>
<link>https://6ix.com/company/mindwalk-holdings-corp/news/mindwalk-to-report-financial-results-and-recent-business-highlights-for-first-quarter-fiscal-year-2026-on-september-15-2025</link>
<guid isPermaLink="true">https://6ix.com/company/mindwalk-holdings-corp/news/mindwalk-to-report-financial-results-and-recent-business-highlights-for-first-quarter-fiscal-year-2026-on-september-15-2025</guid>
<pubDate>Wed, 10 Sep 2025 12:16:00 GMT</pubDate>
<description>AUSTIN, Texas, September 10, 2025--MindWalk (NASDAQ: HYFT) ("HYFT" or the "Company"), a bio-native AI company operating at the intersection of TechBio and next-generation drug discovery, today announced that it will host a conference call to discuss its quarterly results and recent business highlights for first quarter fiscal year end 2026, on Monday, September 15, 2025, at 10:30 am Eastern Time. The financial results will be issued in a press release prior to the call. MindWalk management will</description>
</item>
<item>
<title>IPA’s Subsidiary, BioStrand, Provides an Update on LENSai™</title>
<link>https://6ix.com/company/mindwalk-holdings-corp/news/ipas-subsidiary-biostrand-provides-an-update-on-lensaitm</link>
<guid isPermaLink="true">https://6ix.com/company/mindwalk-holdings-corp/news/ipas-subsidiary-biostrand-provides-an-update-on-lensaitm</guid>
<pubDate>Wed, 25 Oct 2023 04:00:00 GMT</pubDate>
<description>BioStrand Unveils Groundbreaking Retrieval Augmented Generation (RAG)-Based LLM Platform Integrated with Patented HYFT Technology BioStrand's Work</description>
</item>
</channel>
</rss>